Kapoula et al. (56) provide additional data about the role of two biomarkers, KIM-1 and YKL-40, in the development of early diabetic nephropathy, with both being promising biomarkers in the diagnosis of the disease as they can be detectable in early stages and subclinical diseases. Here, CHI3L1 is linked to diabetic kidney disease.